Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis

K Bates Gribbons1, Cristina Ponte2, Simon Carette3

  • 1National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH, Bethesda, Maryland.

Insights

Computer analysis revealed distinct arterial patterns in Takayasu arteritis (TAK) and giant cell arteritis (GCA). These findings differentiate the two large-vessel vasculitides and can inform classification criteria.

Area of Science:

  • Vascular Medicine
  • Rheumatology
  • Medical Imaging

Background:

  • Takayasu arteritis (TAK) and giant cell arteritis (GCA) are large-vessel vasculitides with overlapping clinical features.
  • Distinguishing between TAK and GCA is crucial for appropriate patient management and classification.

Purpose of the Study:

  • To identify and validate distinct patterns of arterial involvement in TAK and GCA using computational methods.
  • To differentiate between TAK and GCA based on their unique vascular disease patterns.

Main Methods:

  • K-means cluster analysis was applied to a combined cohort of 1,068 patients with TAK or GCA from the DCVAS and North American cohorts.
  • Inclusion criteria required evidence of large-vessel involvement via angiography, ultrasonography, or 18F-FDG PET imaging.
  • Identified clusters were validated independently in the North American cohort.

Main Results:

  • Six distinct patient clusters were identified and validated, showing shared and divergent arterial patterns between TAK and GCA.
  • TAK patients more frequently exhibited abdominal, bilateral subclavian/carotid, or isolated left subclavian artery disease.
  • GCA patients were more prone to diffuse disease, bilateral axillary/subclavian involvement, or minimal disease without a clear pattern. GCA also showed higher PET uptake without angiography damage.

Conclusions:

  • Distinct arterial involvement patterns exist for TAK and GCA, aiding in their differentiation.
  • These identified vascular patterns should be considered for inclusion in future classification criteria for large-vessel vasculitis.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
903
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
324
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
380
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
218
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
354
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332